Donna was diagnosed with pancreatic cancer at age 66 when she and her husband were visiting one of their daughters in Australia. When they returned to the U.S., they immediately came to MSK for care, where she learned she was eligible for an investigational vaccine trial, to prevent pancreatic cancer from returning after surgery.
MSK hepatopancreatobiliary surgeon Dr. @Jeffrey_Drebin, physician-scientist @TheVinodLab, and medical oncologist @EileenMOReilly walked Donna through each step.
“They described how they would take part of my tumor to make a personalized vaccine, and it sounded amazing,” Donna says. “My husband and I had a moment of concern about delaying chemotherapy, but all the doctors made me feel so comfortable that we took the leap of faith and said, ‘Go for it.’”
Over the next few months, Donna received an immunotherapy drug and eight doses of the vaccine, followed by chemotherapy, and then a final vaccine dose.
Today, Donna is 72 and recently celebrated her 50th anniversary with her husband in Sicily and spends as much time as she can with her daughters and six grandchildren.
Learn more about this clinical trial, presented at the 2026 American Association for Cancer Research Annual Meeting: https://t.co/C0IwK11OaA
#AACR26
In med school, I learned that Huntington's disease was one of the most devastating inherited conditions. It caused progressive neurological decline, starting around age 30. There was no treatment. Now, Huntington's has been treated for first time.
This is why we fund science.
1/
Why is Ki-67 called Ki-67? And why am I attaching a photo of this beautiful city to the tweet?
If you work in pathology or oncology, you’ve likely come across Ki-67 many times. But where does the name come from?
A short 🧵 on the origins, function, and significance of Ki-67. #IHC #pathx #molpath
𝗚𝗿𝗮𝘁𝗲𝗳𝘂𝗹 🙏
UVA Athletics has received a transformational gift from Alexis Ohanian that will elevate Virginia Women’s Basketball’s recruiting and retention of championship-level talent.
📰 Read More: https://t.co/tsXSUvAOAu
#GoHoos 🔸⚔️🔹 #GNSL
This paper highlights how error bars are often misunderstood, especially regarding statistical significance. Let's explore the key points to clarify these misconceptions. #Statistics#DataScience#Research#OpenScience https://t.co/SCGAZGol0j
Genome editing has centered around DNA, with over 40 ongoing clinical trials and 2 FDA approvals. But RNA editing has some key advantages and appears to be taking off. An open-access review @ScienceMagazine
https://t.co/lWPncM9ujG
Happy to share our little discovery with @SimoneMattei19 team on how ribosomes hibernate upside down on mitochondria during cellular stress is now out @NatureComms! A collaboration between @medicineUVA, @EMBL, @EmblImaging, MEMC. Congrats to all authors! https://t.co/DE6eAamt5I
Aryna Sabalenka will receive $3,600,000 for winning the Women’s event in New York
Jannick Sinner will receive $3,600,000 for winning the Men’s event in New York
They played at the same venue for 2 weeks, they entertained the same crowds, and they WILL get paid the same #USOpen
Why is p53 called p53? 🤔
A 🧵 about the history and discovery of the most studied gene in human history, also known as the guardian of the genome. 🧬 #pathtwitter#pathX#molecular#history
Scientists sequenced Beethoven's genome from a strand of hair and found a funny result.
Applying the gene-wide associations studies to musicality (that we know, there are methodological limits), Beethoven's genetic propensity to musicality was... low?
Kevin Lee, an MS4 @OhioStateMed + newly matched into Neurology was diagnosed with a rare brain cancer in March of 2024.
Since his diagnosis, he’s had a brain biopsy, multiple LPs, and just finished his first round of chemotherapy.
Today, @NEJM published our clinical study of a novel #CARTCell in patients with #Glioblastoma. Early results with CARv3-TEAM-E suggest safety and bioactivity. Special thanks to all collaborators @MGHNeurosurg and @MGHCancerCenter!
https://t.co/ZaDjvVAms7